CN108048520B - 一种利用贝肉制备ace抑制肽的方法 - Google Patents
一种利用贝肉制备ace抑制肽的方法 Download PDFInfo
- Publication number
- CN108048520B CN108048520B CN201810092498.7A CN201810092498A CN108048520B CN 108048520 B CN108048520 B CN 108048520B CN 201810092498 A CN201810092498 A CN 201810092498A CN 108048520 B CN108048520 B CN 108048520B
- Authority
- CN
- China
- Prior art keywords
- magnetic
- shellfish meat
- inhibitory peptide
- microballoon
- ace inhibitory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013372 meat Nutrition 0.000 title claims abstract description 54
- 235000015170 shellfish Nutrition 0.000 title claims abstract description 54
- 101000984728 Chiropsoides quadrigatus Angiotensin-converting enzyme inhibitory peptide Proteins 0.000 title claims abstract description 41
- 238000000034 method Methods 0.000 title claims abstract description 26
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 107
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 52
- 238000001179 sorption measurement Methods 0.000 claims abstract description 37
- 238000000855 fermentation Methods 0.000 claims abstract description 27
- 230000004151 fermentation Effects 0.000 claims abstract description 27
- 241000228245 Aspergillus niger Species 0.000 claims abstract description 12
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 10
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 55
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 42
- 239000007788 liquid Substances 0.000 claims description 35
- 239000000843 powder Substances 0.000 claims description 33
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 31
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 30
- 238000005406 washing Methods 0.000 claims description 25
- 239000012153 distilled water Substances 0.000 claims description 24
- 241000894006 Bacteria Species 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 20
- 238000004821 distillation Methods 0.000 claims description 20
- 238000002360 preparation method Methods 0.000 claims description 20
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical class [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 19
- 239000004005 microsphere Substances 0.000 claims description 17
- 238000004140 cleaning Methods 0.000 claims description 16
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 15
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 14
- 239000001963 growth medium Substances 0.000 claims description 14
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 13
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 239000002131 composite material Substances 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- -1 3-(methacrylyl) propyl Chemical group 0.000 claims description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 10
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 238000010521 absorption reaction Methods 0.000 claims description 9
- 239000003480 eluent Substances 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 230000005389 magnetism Effects 0.000 claims description 8
- 241000790917 Dioxys <bee> Species 0.000 claims description 7
- 229910003978 SiClx Inorganic materials 0.000 claims description 7
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 7
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 6
- 238000007710 freezing Methods 0.000 claims description 6
- 230000008014 freezing Effects 0.000 claims description 6
- 239000002609 medium Substances 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 238000013019 agitation Methods 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 238000011081 inoculation Methods 0.000 claims description 5
- 238000011068 loading method Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 238000009928 pasteurization Methods 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 5
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 239000011541 reaction mixture Substances 0.000 claims description 5
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical class [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 235000011091 sodium acetates Nutrition 0.000 claims description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 2
- 229910000077 silane Inorganic materials 0.000 claims description 2
- 238000010828 elution Methods 0.000 claims 1
- 235000012239 silicon dioxide Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 102000004190 Enzymes Human genes 0.000 abstract description 13
- 108090000790 Enzymes Proteins 0.000 abstract description 13
- 230000036772 blood pressure Effects 0.000 abstract description 5
- 230000002401 inhibitory effect Effects 0.000 abstract description 5
- 238000000605 extraction Methods 0.000 abstract description 2
- 230000001077 hypotensive effect Effects 0.000 abstract description 2
- 229940088598 enzyme Drugs 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 11
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000003276 anti-hypertensive effect Effects 0.000 description 7
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 241001212699 Pinctada martensii Species 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 239000011806 microball Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 3
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 3
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 3
- 229910052814 silicon oxide Inorganic materials 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- 241000237509 Patinopecten sp. Species 0.000 description 2
- 239000006087 Silane Coupling Agent Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000035487 diastolic blood pressure Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000000696 magnetic material Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000020637 scallop Nutrition 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 102000005862 Angiotensin II Human genes 0.000 description 1
- 101800000734 Angiotensin-1 Proteins 0.000 description 1
- 102400000344 Angiotensin-1 Human genes 0.000 description 1
- 101800000733 Angiotensin-2 Proteins 0.000 description 1
- 102000008102 Ankyrins Human genes 0.000 description 1
- 108010049777 Ankyrins Proteins 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 150000004075 acetic anhydrides Chemical class 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- ORWYRWWVDCYOMK-HBZPZAIKSA-N angiotensin I Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 ORWYRWWVDCYOMK-HBZPZAIKSA-N 0.000 description 1
- 229950006323 angiotensin ii Drugs 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- ARYZCSRUUPFYMY-UHFFFAOYSA-N methoxysilane Chemical compound CO[SiH3] ARYZCSRUUPFYMY-UHFFFAOYSA-N 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000005789 organism growth Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 239000002210 silicon-based material Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000025102 vascular smooth muscle contraction Effects 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P39/00—Processes involving microorganisms of different genera in the same process, simultaneously
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810092498.7A CN108048520B (zh) | 2018-01-31 | 2018-01-31 | 一种利用贝肉制备ace抑制肽的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810092498.7A CN108048520B (zh) | 2018-01-31 | 2018-01-31 | 一种利用贝肉制备ace抑制肽的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108048520A CN108048520A (zh) | 2018-05-18 |
CN108048520B true CN108048520B (zh) | 2019-02-12 |
Family
ID=62125292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810092498.7A Active CN108048520B (zh) | 2018-01-31 | 2018-01-31 | 一种利用贝肉制备ace抑制肽的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108048520B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109694409B (zh) * | 2018-11-29 | 2021-03-19 | 中国科学院南海海洋研究所 | 一种血管紧张素转化酶抑制活性功能肽及其应用 |
CN114712400A (zh) * | 2022-04-13 | 2022-07-08 | 济南瑞隆安生物技术有限公司 | 可降血糖降血压的益生菌发酵蛤蜊粉组合物及制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104001474A (zh) * | 2014-05-20 | 2014-08-27 | 江苏大学 | 一种碳包覆四氧化三铁核壳纳米粒子及其制备方法 |
CN107163130A (zh) * | 2017-06-08 | 2017-09-15 | 广西大学 | 一种血管紧张素转化酶抑制肽及其制备提取方法 |
CN107551987A (zh) * | 2017-10-19 | 2018-01-09 | 兰州大学 | 一种磁性吸附剂及其制备方法和用途 |
CN107586318A (zh) * | 2017-05-25 | 2018-01-16 | 青岛大学 | 一种降血压肽及其制备方法 |
-
2018
- 2018-01-31 CN CN201810092498.7A patent/CN108048520B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104001474A (zh) * | 2014-05-20 | 2014-08-27 | 江苏大学 | 一种碳包覆四氧化三铁核壳纳米粒子及其制备方法 |
CN107586318A (zh) * | 2017-05-25 | 2018-01-16 | 青岛大学 | 一种降血压肽及其制备方法 |
CN107163130A (zh) * | 2017-06-08 | 2017-09-15 | 广西大学 | 一种血管紧张素转化酶抑制肽及其制备提取方法 |
CN107551987A (zh) * | 2017-10-19 | 2018-01-09 | 兰州大学 | 一种磁性吸附剂及其制备方法和用途 |
Non-Patent Citations (3)
Title |
---|
微生物发酵法制备大豆ACE抑制肽菌种的筛选;李响等;《食品科学》;20131231;第34卷(第1期);第185-188页 |
炭活化一步法制备豆渣基极微孔活性炭;李大伟等;《农业工程学报》;20151031;第31卷(第19期);第309-314页 |
瑞士乳杆菌发酵乳ACE抑制肽的研究;郭彦平等;《中国食品添加剂》;20091231;第121-124页 |
Also Published As
Publication number | Publication date |
---|---|
CN108048520A (zh) | 2018-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104388514B (zh) | 利用复合菌种发酵制备γ‑氨基丁酸的方法 | |
CN102318724B (zh) | 一种酸性大豆多肽蛋白的生产方法 | |
CN106119173B (zh) | 一种无苦味的虾类低分子肽及其制备方法与应用 | |
WO2021017695A1 (zh) | 一种不致腹胀的豆浆粉及其制作方法 | |
WO2018103118A1 (zh) | 一种发酵型大豆乳清饮料及其制备方法 | |
CN106916861B (zh) | 一种同时生产木耳多糖和黑色素的方法 | |
CN104109622B (zh) | 一种富硒食醋的制备方法 | |
CN105624249A (zh) | 一种水产蛋白-植物蛋白复合型活性肽的制备方法 | |
CN108048520B (zh) | 一种利用贝肉制备ace抑制肽的方法 | |
CN101126103A (zh) | 微生物发酵法制备高f值玉米蛋白肽的方法 | |
CN109554302B (zh) | 一种利用固定化细胞技术发酵生产饲用酶制剂的方法 | |
CN110495611A (zh) | 一种提高海参营养保健功效的工艺 | |
CN107058209A (zh) | 一种采用载体吸附进行黑曲霉孢子增殖及其干孢子粉的制备方法 | |
CN105767954A (zh) | 一种利用纳豆菌发酵鲜贝肉制备降血压功能食品的方法 | |
CN1239711C (zh) | 一种无苦味的大豆多肽及其生产方法 | |
CN109880874A (zh) | 一种大米活性肽的制备方法、大米活性肽及其应用 | |
CN101168762B (zh) | 一种发酵法利用带鱼脊骨制备降血压肽的方法 | |
CN106578348A (zh) | 一种溶菌酶饲料添加剂的制备方法及应用 | |
CN106929489B (zh) | 一种耐热耐酸葡萄糖氧化酶的发酵制备及分离纯化方法 | |
CN101654693B (zh) | 微生物发酵制备菜籽肽的方法 | |
CN109943602A (zh) | 一种酵母菌发酵法制备神经酰胺的工艺 | |
CN114317657B (zh) | 一种鱼骨肽及其制备方法和应用 | |
CN115385980A (zh) | 一种坛紫菜源胰脂肪酶抑制肽及其制备方法和应用 | |
CN114617190A (zh) | 一种利用南极磷虾制备的功能性饲料蛋白及其方法 | |
CN114271505A (zh) | 一种促进鼠李糖乳杆菌增殖的添加剂、制备方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wei Jian Inventor after: Jia Guixiang Inventor after: Zhou Wenliao Inventor before: Zhou Wenliao |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181213 Address after: 266071 Block C 9E, 37 Donghai West Road, Shinan District, Qingdao City, Shandong Province Applicant after: Qingdao High Tech Co.,Ltd. Address before: No. 47 Zileipo, Wuhe Village, Xianhu Development Zone, Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region, 530000 Applicant before: Zhou Wenliao |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210906 Address after: 314400 a806, 128 Shuanglian Road, Haining Economic Development Zone, Haining City, Jiaxing City, Zhejiang Province Patentee after: JIAXING SHINING TECH Co.,Ltd. Address before: 266071 Block C 9E, 37 Donghai West Road, Shinan District, Qingdao City, Shandong Province Patentee before: Qingdao High Tech Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211022 Address after: 1f, Wanchai Revenue Tower, 5 Gloucester Road, Wanchai, Hong Kong, China Patentee after: European and American biotechnology incubation and Transfer Center (Hong Kong) Co.,Ltd. Address before: 314400 a806, 128 Shuanglian Road, Haining Economic Development Zone, Haining City, Jiaxing City, Zhejiang Province Patentee before: JIAXING SHINING TECH Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240710 Address after: 464000 Genqin Cultural Integration Industrial Park C-092, 15th Floor, Yihe Capital Building, Gushi County, Xinyang City, Henan Province Patentee after: Xinyang Dingyong Information Technology Service Center (sole proprietorship) Country or region after: China Address before: 1f, Wanchai Revenue Tower, 5 Gloucester Road, Wanchai, Hong Kong, China Patentee before: European and American biotechnology incubation and Transfer Center (Hong Kong) Co.,Ltd. Country or region before: Hong-Kong |